CASC2 and Sepsis: Susceptibility cancer candidate 2 (CASC2) expression was significantly reduced in sepsis patient serum and LPS-treated HK2 and HEK293 cells, with levels inversely correlating with the severity of AKI and pro-inflammatory miR-155.